Original Investigation4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation
Under an Elsevier user license
open archive
Central Illustration
Key Words
atrial fibrillation
cardioembolism
dire oral anticoagulant
left atrial appendage closure
oral anticoagulation
Abbreviations and Acronyms
AF
atrial fibrillation
CV
cardiovascular
DAPT
dual antiplatelet treatment
DOAC
direct oral anticoagulant
IQR
interquartile range
ITT
intention-to-treat
LA
left atrial
LAA
left atrial appendage
LAAC
left atrial appendage closure
mITT
modified intention-to-treat
OAC
oral anticoagulant
SE
systemic embolism
sHR
subdistribution HR
TEE
transesophageal echocardiography
TIA
transient ischemic attack
Cited by (0)
Faisal Merchant, MD, served as Guest Associate Editor for this paper. Javed Butler, MD, MPH, MBA, served as Guest Editor-in-Chief for this paper.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.
- ∗
Drs Widimsky and Reddy are joint senior authors.
© 2022 by the American College of Cardiology Foundation. Published by Elsevier.